Related Experiment Video
Updated: Aug 9, 2026
06:54
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Pro-metastasis function of TGFbeta mediated by the Smad pathway
1Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544, USA. ykang@molbio.princeton.edu
Journal of Cellular Biochemistry
|April 7, 2006
Summary
Transforming growth factor beta (TGFbeta) signaling involves Smad proteins, crucial for tissue growth and cancer suppression. New research reveals Smad proteins can paradoxically promote cancer metastasis, impacting therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- The transforming growth factor beta (TGFbeta) pathway is crucial for normal tissue development and homeostasis.
- Dysregulation of the TGFbeta pathway is implicated in cancer initiation and progression.
- Smad proteins are key signal transducers in the TGFbeta pathway, mediating its tumor suppressive functions.
Purpose of the Study:
- To elucidate the poorly defined role and mechanism of Smad proteins in cancer metastasis.
- To investigate the Smad-dependent mechanisms by which TGFbeta promotes cancer metastasis.
- To understand the dual roles of Smad proteins in both tumor initiation and progression for therapeutic implications.
Main Methods:
- Utilized genetically modified cancer cell lines.
- Employed mouse tumor models.
- Analyzed Smad protein function in TGFbeta-mediated metastasis.
Main Results:
- Provided concrete evidence for a Smad-dependent mechanism promoting cancer metastasis via TGFbeta.
- Demonstrated that TGFbeta signaling through Smads can drive tumor progression.
- Highlighted the complex, dual role of Smads in cancer.
Conclusions:
- Smad proteins play a critical, albeit complex, role in cancer metastasis.
- Understanding Smad protein involvement in metastasis is essential for developing effective cancer therapeutics.
- Targeting the TGFbeta-Smad pathway may offer novel therapeutic avenues for cancer treatment.
Related Concept Videos
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...